Clarus Lifesciences I, L.P.'s Net Worth
$42.7 Million
Who is Clarus Lifesciences I, L.P.?
Clarus Lifesciences I, L.P. has an estimated net worth of $42.7 Million. This is based on reported shares across multiple companies, which include GLOBUS MEDICAL INC, ZOGENIX, INC., Oxford Immunotec Global PLC, AVANIR PHARMACEUTICALS, INC., Sientra, Inc., and VBI VACCINES INC..
SEC CIK
Clarus Lifesciences I, L.P.'s CIK is 0001431445
Past Insider Trading and Trends
2010 was Clarus Lifesciences I, L.P.'s most active year for acquiring shares with 4 total transactions. Clarus Lifesciences I, L.P.'s most active month to acquire stocks was the month of October. 2015 was Clarus Lifesciences I, L.P.'s most active year for disposing of shares, totalling 15 transactions. Clarus Lifesciences I, L.P.'s most active month to dispose stocks was the month of October. 2011 saw Clarus Lifesciences I, L.P. paying a total of $7,000,000.00 for 3,500,000 shares, this is the most they've acquired in one year. In 2010 Clarus Lifesciences I, L.P. cashed out on 49,921,272 shares for a total of $42,734,278.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.24M |
—
|
—
|
0
|
Sep 3
| |||
Form 4
| +1,098.85% | 6.64M |
$11.16 | -$8,975,229.12 | 7.24M |
Aug 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZOGENIX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +58.50% | 3.5M |
$2.00 | $7,000,000.00 | 9.48M |
Sep 16
| |||
Form 4
|
∞
| 5.98M |
$4.00 |
—
| 5.98M |
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVANIR PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.67M |
—
|
—
| 12 |
Dec 3
| |||
Form 4
| -15.73% | -1.24M |
$4.82 | -$6,001,512.60 | 6.67M |
Nov 8 - Nov 9
| |||
Form 4
| -17.96% | -1.73M |
$4.58 | -$7,929,916.00 | 7.91M |
Nov 3 - Nov 5
| |||
Form 4
| -35.00% | -5.19M |
$5.06 | -$26,289,470.55 | 9.65M |
Oct 29 - Nov 2
| |||
Form 4
| -3.59% | -551.84K |
$3.50 | -$1,930,236.53 | 14.84M |
Oct 8 - Oct 11
| |||
Form 4
| -1.06% | -165.00K |
$3.53 | -$583,143.00 | 15.39M |
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oxford Immunotec Global PLC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.81% | -41.23K |
$14.30 | -$589,543.13 | 2.24M |
Jun 15 - Jun 16
| |||
Form 4
| -1.37% | -31.60K |
$14.27 | -$450,774.86 | 2.28M |
Jun 11 - Jun 12
| |||
Form 4
| -1.06% | -24.65K |
$14.28 | -$352,007.34 | 2.31M |
Jun 8 - Jun 10
| |||
Form 4
| -1.54% | -36.47K |
$14.29 | -$521,086.40 | 2.33M |
Jun 1 - Jun 3
| |||
Form 4
| -2.20% | -53.41K |
$14.49 | -$773,752.95 | 2.37M |
Mar 20 - Mar 23
| |||
Form 4
| -5.98% | -154.32K |
$14.65 | -$2,261,109.01 | 2.42M |
Mar 17 - Mar 19
| |||
Form 4
|
∞
| 2.58M |
—
|
—
| 2.58M |
Nov 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sientra, Inc. (SIEN) Snapshot price: $0.5996
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||